Copenhagen Pharma Consulting ApS
Private limited companyCVR 41537388VanløseActive
Copenhagen Pharma Consulting ApS is a private limited company, based in Vanløse, active in other professional, scientific and technical activities n.e.c., founded in 2020. Net profit fell 25% from 2024 to 2025, ending at DKK 420k. Equity fell to DKK 602k in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 29% (2024 → 2025), to DKK 3.4m.
- Net profit fell 25% (2024 → 2025), to DKK 420k.
- Equity fell 64% (2024 → 2025), to DKK 602k.
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2024–2025 · amounts in DKK thousandEquity and net profit
| 2024 | 2025 | Change | |
|---|---|---|---|
| Revenue | not stated | not stated | – |
| Gross profit | 2,617 | 3,364 | +28.5% |
| Profit before tax | 716 | 539 | −24.7% |
| Net profit | 558 | 420 | −24.8% |
| Total assets | 2,402 | 1,455 | −39.4% |
| Equity | 1,682 | 602 | −64.2% |
| Liabilities | 720 | 853 | +18.6% |
| Cash and cash equivalents | 694 | 214 | −69.1% |
| Average number of employees | 2 | 2 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresEquity fell sharply
Equity fell 64% from 2024 to 2025 (DKK 1.7m to DKK 602k).
How is this calculated?
Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
2 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 16/04/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 25/03/2025 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
310 companies in the databaseComparison with the other companies in other professional, scientific and technical activities n.e.c. based on the latest financial year.
Industry median: gross profit DKK 1.9m, net profit DKK 142k, equity DKK 1.1m, 2 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 20,363of 69,742 Better than 71% | No. 40,004of 69,964 Better than 43% |
| Same industry and fewer than 20 employees281 companies in the comparison | No. 93of 281 Better than 67% | No. 163of 281 Better than 42% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 12,019of 33,588 Better than 64% | No. 18,758of 33,687 Better than 44% |
| All companies of type ApS66,508 companies in the comparison | No. 20,227of 66,379 Better than 70% | No. 35,913of 66,505 Better than 46% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Other professional, scientific and technical activities n.e.c.- Copenhagen Pharma Consulting ApSDKK 3.4m
- Clearwater Denmark K/SDKK 251.1m
- Bureau Veritas Denmark A/SDKK 149.1m
- Copenhagen Pharma Consulting ApSDKK 420k
- Clearwater Denmark K/SDKK 134.2m
- Bureau Veritas Denmark A/SDKK 17.3m
- Copenhagen Pharma Consulting ApSDKK 602k
- Clearwater Denmark K/SDKK 76.4m
- Bureau Veritas Denmark A/SDKK 18.7m
- Copenhagen Pharma Consulting ApS2
- Clearwater Denmark K/S56
- Bureau Veritas Denmark A/S161
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Obi1 Holding ApS100%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Lars Holten-Andersen | CEO | 23/07/2020 |
- Founders
- Lars Holten-Andersen
Signing rule: Virksomheden tegnes af direktionen
Address and production units
1 active production unitsRødtjørnevej 8
2720 Vanløse
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Copenhagen Pharma Consulting ApS | Rødtjørnevej 8, st, 2720 Vanløse | 2 | 1026057147 |
Purpose
Virksomhedens formål er at drive konsulentvirksomhed fokuseret på forsknings- og udviklingsopgaver for firmaer indenfor biotek og pharma og hermed forbundet virksomhed
The purpose is quoted from the register in Danish.
Changes year by year
7 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20251 changeaccounts 1
- AccountsAnnual report for 2024 published
20222 changesownership 2
- OwnershipObi1 Holding ApS registered as owner (100%)
- OwnershipLars Holten-Andersen is no longer registered as owner
20203 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as Copenhagen Pharma Consulting ApS
- ManagementLars Holten-Andersen appointed ceo
- OwnershipLars Holten-Andersen registered as owner (100%)
Related companies
Same industry in København
- Zacco Denmark A/S102 employees
- Ardmac ApS97 employees
- emendo Project Consulting ApS33 employees
- Amsterdam Data Collective Denmark A/S31 employees
- BARK Rådgivning A/S26 employees
- emendo R & D ApS23 employees
Largest in the industry
- Clearwater Denmark K/SDKK 251.1m
- Bureau Veritas Denmark A/SDKK 149.1m
- Zacco Denmark A/SDKK 111.2m
- AS1 Sports Nordic ApSDKK 56.2m
- Dge A/SDKK 46.9m
- Neurons Inc. ApSDKK 43.9m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.